Additional Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Saint John's A1B 3V6
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Ann Arbor MI. 48109-5360
    View Details

  • A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    GSK Investigational Site
    Rochester MN. 55905
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Move With Air: Physiological Response Assessment

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • Move With Air: Exercise Training Study

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Temple University
    Philadelphia PA. 19140
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Cleveland Clinic
    Cleveland OH. 44195
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Royal University Hospital (Saskatoon)
    Saskatoon SK. S7N 0W8
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Northern Westchester Hospital
    Mount Kisco NY. 10549
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    St. Joseph's Healthcare Hamilton
    Hamilton ON. L8N 1Y2
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Georgetown University
    Washington DC. 20007
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Centre Hospitalier de l'Universite de Montreal (CHUM)
    Montreal QC. H2X 0C1
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    McGill University Health Centre (MUHC)
    Montreal QC. H4A 3J1
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    NewYork-Presbyterian/Weill Cornell Medical Center
    New York NY. 10065
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    University of Utah Health Sciences Center
    Salt Lake City UT. 84108
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Beth Israel Deaconess Medical Center
    Boston MA. 02215
    View Details